Interestingly, our meta-analysis also indicated a trend of ANGPT2 upregulation across several cancer types, including colon, esophageal, glioblastoma, stomach, hepatocellular, and renal clear cell carcinomas, suggesting its involvement in tumour progression. Here, ANGPT2 is linked to clear cell renal carcinoma.